Search results
Trying juveniles as adults is not the answer
The Hindu· 54 minutes agoIn May, a speeding car, allegedly driven by a teenager, killed two young techies in Pune. As prescribed by the Juvenile Justice (Care and Protection of...
Urological Diseases In Men: Expert Shares Symptoms, Ways To Identify, And Effective Treatment...
Times Now· 1 hour agoUrological diseases in men, including conditions such as prostate cancer, benign prostatic...
GD Goenka University Successfully Hosts National Level School Counsellors Summit on
SiliconIndia· 3 hours agoGD Goenka University, in collaboration with Fortis Hospital, successfully organised a two-day...
Revolution sets sights on Phase III trial for pan-RAS inhibitor
Pharmaceutical Technology· 4 hours agoThe study will compare the 300mg dose of RMC-6236 to the investigator’s choice of standard...
Research Reveals Three-Months Long Wait For Cancer Treatment Triples In 5 Years In UK
Times Now· 4 hours agoCancer Research UK has warned that very long waits for NHS cancer treatment have tripled since 2017....
Aldosterone Function and Signs of Imbalance
Verywell Health· 5 hours ago(high blood pressure) Low potassium levels Muscle cramping Spasms Thirst Treatment Options for Aldosterone Disorders Treatment for hypoaldosteronism...
German CDMO outlays $980m on GLP-1 manufacturing expansion
Pharmaceutical Technology· 5 hours agoOver the years, GLP-1 receptor agonist therapies have taken over the diabetes and weight loss...
Mangaluru: Renowned author, 'Laughter Guru' John B Monteiro passes away at 86
Daiji World· 5 hours agoMangaluru, Jul 16: Renowned author, 'Laughter Guru' and founder of the Bondel Laughter Club, John B...
Kyverna wins RMAT designation for stiff-person syndrome for cell therapy candidate
Pharmaceutical Technology· 5 hours agoAn RMAT designation includes those benefits included in the fast track and breakthrough therapy...
SOTIO partners with Biocytogen to expand ADC oncology pipeline
Pharmaceutical Technology· 6 hours agoOther Phase I/II candidates include BOXR1030, a metabolically-enhanced CAR-T cell therapy targeting...
